Friday, February 21, 2025 | 11:11 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Pharmaceutical companies, CDSCO to discuss regulatory matters on Friday

It is expected that representatives for MSMEs pharma manufacturers may raise the issue of extension of Revised Schedule M implementation timelines

pharmaceutical sector, pharma
Premium

Sanket KoulSohini Das New Delhi/Mumbai

Listen to This Article

Representatives from several pharmaceutical lobby groups are set to meet officials of the Central Drugs Standard Control Organisation (CDSCO) today, and the Schedule M implementation will be on the agenda, said people privy to the development.
 
Schedule M, which sets quality standards and good manufacturing practices (GMP) for pharmaceutical companies, was notified by the health ministry in January last year and came into effect on January 1, 2025.
 
"Each industry body has been asked to send their presentations in advance. Everyone will be given five minutes to present their points," a member of an industry body said, adding that they

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in